OSUR

$OSUR chatter on StockTwits

• 
  jorge .miguel@focafoca99Aug 5

  $OSUR released its Q2 2026 financial results via a press release on August 5.

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsAug 5

  $OSUR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.09 up 134.62% YoY • Reported revenue of $30.64M down -1.93% YoY • OraSure Technologies is guiding to Q3 2026 total revenues of $29.5 million to $32.5 million, reflecting the company's outlook for the upcoming period based on current business and market conditions.

  View on StockTwits ↗
• 
  Squeezy@TheRealShortSqueezyBullishJul 15

  🧬 $INBS : Could FDA Approval Unlock the Next Leg Higher? Intelligent Bio Solutions is developing a fingerprint based drug screening system that delivers fast, non invasive testing On June 16, the company kicked off another FDA clinical study, marking another step toward its planned 510(k) submission and potential entry into the U.S. drug testing market Recent Highlights: 🔹 FDA clinical program remains on track 🔹 135-patient U.S. multi site study underway 🔹 Operating in 35+ countries with 480+ active customer accounts 🔹 Q3 revenue increased 46% YoY to $1.06M 🔹 Nine-month revenue reached $3.07M, up 39% YoY 🔹 Gross margin climbed above 50% 🔹 Cash position increased to $6.86M 🔹 Secured its 8th European patent while expanding manufacturing capacity With several FDA milestones ahead, growing commercial traction, and improving financials, INBS looks like one to keep on the watchlist Communicated Disclaimer: https://stockresearchtoday.com/inbs/ Sector Peers : $OSUR $QDEL $DGX $LH

  View on StockTwits ↗
• 
  Ageslow@AgeslowJun 24

  $OSUR could get Sherlock approval soon, it opens the door to a $1.5B STI testing market with the first true one-of-a-kind disposable molecular self-test — 30-min results from a swab, far faster and more user-friendly than today’s lab PCR tests. Estimated price per test: $6–15 vs lab equivalents $50–100+. This could be worth multiples of current revenue. Share price could increase 2–5x in not to distant future.

  View on StockTwits ↗
• 
  DARKP00L@DARKP00LJun 11

  $OSUR 08:07 on Jun. 11 2026 OraSure Technologies Subsidiary DNA Genotek Receives FDA Clearance For Urine Collection Kits Use In Roche's STD Screening Kits #tradeideas

  View on StockTwits ↗
• 
  MBSB@MBSBMay 28

  $OSUR i wonder if US will puchase tests for the upcoming World Cup…

  View on StockTwits ↗
• 
  Estimize@EstimizeMay 27

  Wall St is expecting -0.18 EPS for $OSUR Q2 [Reporting 08/11 AMC] http://www.estimize.com/intro/osur?chart=historical&metric_name=eps&utm_c

  View on StockTwits ↗
• 
  Bill Coe@Bill614May 26

  $OSUR Could this be the reason Orasure has spiked over the last two trading sessions? “The OraQuick Ebola Rapid Antigen Test by OraSure Technologies is the first FDA-cleared rapid diagnostic test for Ebola. It provides presumptive detection of Ebola virus antigens in about 4-30 minutes and is used exclusively for symptomatic individuals or to screen recently deceased individuals.”

  View on StockTwits ↗
• 
  Insanity Wolf@insanitywolftradingMay 21

  $OSUR $CODX both have done well but the PPE stocks are virgin territory that have not seen a major flow of volume into them yet, just trailblazers

  View on StockTwits ↗
• 
  TI7812 Don't Fight The Fed@TI7812May 21

  $OSUR MACD is pretty close to bullish crossover...but looks like holding between 2.89 and 3.25 till FDA decision

  View on StockTwits ↗
• 
  TI7812 Don't Fight The Fed@TI7812May 21

  $OSUR got idea from @Hkuppy free KEDM sub. LLM AI - i forgot which one I used. lol. GROK GEMINI CLAUDE, I just don't remember. but it does look like Gemini's style. Especially like the cash per share from a R/R. GTLA

  View on StockTwits ↗
• 
  Deepthinker@deepthinkerMay 15

  $OSUR They’ll be down to about $90 million at end of 2027. So, they’ll have spent $200 million for not much in terms of revenue growth. I can see why activists might be frustrated.

  View on StockTwits ↗
• 
  Runner Signals@RunnerSignalsMay 8

  $OSUR vol 4.1x on a +4.33% move. RSI 56, room to 70. Above MA50 and MA200. MACD confirmed same session

  View on StockTwits ↗
• 
  jorge .miguel@focafoca99May 6

  $OSUR released its quarter ended March 31, 2026 financial results and held a webcast.

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsMay 6

  $OSUR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.32 down -52.38% YoY • Reported revenue of $27.93M down -6.70% YoY • OraSure Technologies anticipates Q2 2026 total revenues to be in the range of $27M to $30M, reflecting the company's outlook for the upcoming quarter.

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.